Market cap ⓘTotal market value of the company's outstanding shares, calculated by multiplying the share price by the number of shares outstanding.365.6B$, 2026▼52.6% YoY
Revenue ⓘTotal revenue reported in the company's financial statements for the specified reporting year, reflecting income generated from primary business activities. Expressed in millions of USD.400.3B$, 2025▼2.8% YoY
R&D intensity ⓘResearch and development expenditure expressed as a percentage of revenue, reflecting the company's relative investment in innovation.3.11%2025
Denka's chloroprene production at the Denka Performance Elastomer facility in LaPlace Louisiana has been subject to sustained EPA enforcement action over elevated cancer risks in surrounding majorityBlack 'Cancer Alley' communities.